Japanese registry finds use of IVUS in coronary interventions reduces mortality and need for coronary bypass surgery
2023-10-24
(Press-News.org) SAN FRANCISCO – A novel study conducted by a Japanese multicenter registry has revealed the significant benefits of using intravascular ultrasound (IVUS) in coronary intervention procedures. The comprehensive analysis, which focused on enhancing patient outcomes, has provided valuable insights into the effectiveness of IVUS in improving the success rates of these interventions.
The study, titled "Enhancing coronary intervention outcomes with the use of intravascular ultrasound: A comprehensive analysis of long-term benefits in Japanese multicenter registry," sheds light on the positive impact of IVUS on coronary interventions. The findings, presented today at TCT 2023 and published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), highlight the strong benefits of incorporating IVUS into standard practice for coronary interventions.
Coronary intervention procedures, such as angioplasty and stenting, are commonly performed to treat coronary artery disease. IVUS is a medical imaging technique that allows physicians to visualize the inside of blood vessels, providing detailed information about plaque buildup and vessel dimensions. By utilizing IVUS during these procedures, physicians can make more informed decisions and optimize treatment strategies.
The Japanese multicenter registry, which included data from 8,721 patients in a multicenter PCI registry, demonstrated that the use of IVUS led to reduced mortality and need for coronary bypass surgery. The analysis revealed that reduced incidence of major adverse cardiac events, and improved long-term clinical outcomes in patients who underwent IVUS-guided procedures.
The registry findings showed that 83.8 % of patients underwent IVUS-guided PCI (mean age 68.3±11.3 years). After adjustments, the IVUS group had significantly lower rates of death and coronary bypass compared to no IVUS group (HR [95% CI]: 0.73 [0.55-0.96], 0.62 [0.39-0.98]) at the 2-year follow-up, although the primary outcome showed only marginal differences (HR [95% CI]: 0.85 [0.71-1.01]). In the subgroup analysis of complex coronary anatomy, the use of IVUS was significantly associated with a reduced risk of the primary outcome (HR [95% CI]: 0.72 [0.55-0.93]) as well as death, coronary bypass, heart failure.
Toshiki Kuno, MD, PhD, lead researcher of the study, emphasized the importance of these findings. "Our study provides robust evidence supporting the use of IVUS in coronary interventions. By visualizing the coronary arteries in real-time, physicians can accurately assess the severity of the disease and optimize stent placement, ultimately leading to better patient outcomes."
As the use of IVUS continues to gain recognition as a valuable tool in coronary interventions, further research and collaboration is critical to fully understand its potential and optimize its utilization. This registry studies advancing the field of coronary intervention and paves the way for improved patient care and outcomes.
Session details: Moderated Abstracts Station 8 – Emerging Clinical Science & Research; Tuesday, October 24, 2023, 10:00 AM PDT.
###
About SCAI
The Society for Cardiovascular Angiography & Interventions (SCAI) is a non-profit professional association with over 4,500 members representing interventional cardiologists and cardiac catheterization teams in the United States. SCAI promotes excellence in interventional cardiovascular medicine for both adults and children through education, representation, and the advancement of quality standards to enhance patient care. Follow @SCAI on Twitter for the latest heart health news.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-24
Philadelphia, PA., October 24, 2023
WHO: The Gabriella Miller Kids First Pediatric Research Program (Kids First), an initiative of the National Institutes of Health (NIH)
WHAT: Kids First announces the release of nine robust new pediatric research datasets spanning childhood cancers, congenital disorders, and cross-condition data. New publicly available datasets include:
PEDIATRIC CROSS-CONDITION
Kids First and INCLUDE: Down Syndrome, Heart Defects, and Acute Lymphoblastic Leukemia
Principal ...
2023-10-24
In a new case report, researchers at UCLA Health describe promising results using repetitive transcranial magnetic stimulation (rTMS) in the management of post-stroke cerebellar ataxia, a debilitating condition marked by impaired coordination and balance.
Cerebellar ataxia describes a group of neurological disorders that affect coordination, balance, and control of muscle movements. It results from damage or dysfunction of the cerebellum, a part of the brain responsible for coordinating voluntary movements. Ataxia can manifest as unsteady walking, difficulties with fine motor skills, and problems with speech, ...
2023-10-24
Lingjia Liu, professor of electrical and computer engineering who is also an inaugural faculty member at the Virginia Tech Innovation Campus, has been awarded the Mobile Distributed Multiple-Input, Multiple-Output (Mobile dMIMO) project by the U.S. Department of Defense’s (DoD’s) Office of the Under Secretary of Defense for Research and Engineering (OUSD(R&E)) as part of its flagship FutureG program. The Mobile dMIMO project consists of three phases, with $9 million total planned funding — $1.5 million is for Phase 1 of the project. The Mobile dMIMO project represents one ...
2023-10-24
Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions, such as Alzheimer’s disease and traumatic brain injury, at low cost—and do so accurately regardless of their skin tone.
The technology, published in Scientific Reports, has the potential to improve the equity and accessibility of neurological screening procedures while making them widely available on all smartphone models.
The attachment fits over a smartphone’s camera and improves its ...
2023-10-24
Gene therapy currently represents the most promising approach for the treatment of hereditary diseases. Yet despite significant breakthroughs in recent years, there are still a number of hurdles that hinder the wider application of gene therapies. These include the efficient delivery of genetic material into target cells with minimal side effects using adeno-associated viral vectors (AAVs). The AAV carrier substances have an advantageous safety profile and high gene transfer efficiency, meaning they are often used in gene therapies and in gene editing with CRISPR/Cas. But, AAVs have limited DNA uptake capacity ...
2023-10-24
An artificial intelligence tool effectively detected distress in hospital workers’ conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.
As the coronavirus pandemic forced many hospitals to operate beyond capacity, medical workers faced overwhelming numbers of work shifts, limited rest, and increased risk of COVID-19 infection. At the same time, quarantine policies and fear of infecting family reduced their ...
2023-10-24
If you’ve ever watched a bumblebee move from flower to flower, you might wonder how they decide which flower to choose and how long to stay. Now, researchers reporting in the journal iScience on October 24 have new insight based on their observations of bumblebees’ interactions with slippery artificial flowers. They found that the bumblebees make choices to maximize the rate of energy return, or the amount of sugar collected each minute.
“Bumblebees can make decisions ‘on the fly’ about which nectar sources are the most energetically economical,” said Jonathan ...
2023-10-24
When it comes to the question of who gets to be a scientist, gender disparities are well-documented in many fields. Patching the infamous “leaky pipeline” can be a thorny problem, but during the 2022–2023 school year, the Department of Chemistry at the University of Oxford took a simple and practical step forward: they began offering period products in the department’s bathrooms. In an article publishing October 25 in the journal Trends in Chemistry, three students involved in the Oxford Period Project and their supervising ...
2023-10-24
About The Study: In this randomized clinical trial of 3,777 patients with ST-segment elevation myocardial infarction (STEMI; a type of heart attack), the Chinese patent medicine Tongxinluo, as an adjunctive therapy in addition to STEMI guideline-directed treatments, significantly improved both 30-day and 1-year clinical outcomes. Further research is needed to determine the mechanism of action of Tongxinluo in STEMI.
Authors: Yuejin Yang, M.D., Ph.D., and Runlin Gao, M.D., of the Chinese Academy of Medical ...
2023-10-24
Research has found that bumblebees make foraging choices to collect the most sugar from flowers in the shortest time – even if that means using more energy in the process – to provide an immediate energy boost for the colony.
A new study investigating nectar drinking in one of the most common bumblebees in the UK, Bombus terrestris, has found that when foraging they maximise the amount of nectar sugar they take back to the colony each minute.
To make their choices, the bumblebees trade off the time they spend collecting nectar with the energy content of that nectar. This means ...
LAST 30 PRESS RELEASES:
[Press-News.org] Japanese registry finds use of IVUS in coronary interventions reduces mortality and need for coronary bypass surgery
